Teva Announces Launch of a Generic Version of VESIcare (solifenacin succinate) Tablets in the United States Read more
Pfizer and Lilly Announce Top-Line Results From Long-Term Phase 3 Study of Tanezumab in Patients With Osteoarthritis Read more
China based innovation, CDMOs and Parallel Approvals driving huge growth in manufacturing at CPhI China Read more
SK Biopharmaceuticals and twoXAR Sign Collaboration Agreement to Discover and Develop First-In-Class Treatments for Non-Small Cell Lung Cancer Read more
CASI Pharma In-Licenses Exclusive Worldwide Rights to Novel Anti-CD38 Monoclonal Antibody Program From Black Belt Therapeutics Read more
STC Biologics becomes the largest biologics CDMO within five miles of Cambridge, MA after addition of its new GMP manufacturing facility Read more